Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,260.80 +253.49 1.95%
Hang Seng 21,137.10 -88.83 -0.42%
S&P/ASX 200 4,834.90 +20.55 0.43%
  • Exchange: Dublin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Merrion Pharmaceuticals Ltd

+ Add to Watchlist

MERR:ID

0.5950 EUR 0.00000.00%

As of 12:10:02 ET on 06/13/2013.

Snapshot for Merrion Pharmaceuticals Ltd (MERR)

Open: - Day's Range: - Volume: 123,645
Previous Close: 0.5950 52wk Range: 0.2000 - 0.6400 1-Yr Rtn: +197.50%

Stock Chart for MERR

No chart data available.
  • MERR:ID 0.5950
  • 1D
  • 1M
  • 1Y
0.5950
Interactive MERR Chart

Previous Close

Key Statistics for MERR

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. ISEQ -
Earnings Per Share (EUR) (ttm) -0.4152
Est. EPS (EUR) (12/2012) -0.0580
Est. PEG Ratio -
Market Cap (M EUR) 10.19
Shares Outstanding (M) 17.13
30 Day Average Volume 7,578
Price/Book (mrq) -
Price/Sale (ttm) 34.4990
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 09/27/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MERR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MERR

Merrion Pharmaceuticals Ltd is a pharmaceutical company. The Company develops drug delivery technologies to improve absorption in the gastrointestinal tract.

More Company Profile & Key Executives for MERR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil